Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy
Drug Science Policy and Law January 1, 2017 DOI: 10.1177/2050324517723232 via OpenAlex
Summary
AI-generated from the abstractPsychedelic drugs may enhance well-being in healthy individuals, not just treat mental health problems. Contemporary research on neurobiological and subjective effects in healthy people suggests potential benefits for well-being, while the low risk of use contrasts with strict drug laws and heavy penalties. The review considers policy implications and future research directions.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Population | Healthy individuals |
| Keywords | Mental health Drug Psychology Psychiatry Medicine |
| Citations | 59 |
| Key finding | Psychedelic drugs may enhance well-being in healthy individuals, and the low risk of use does not align with stringent drug laws. |
Abstract
The potential of psychedelic drugs in the treatment of mental health problems is increasingly being recognized. However, relatively little thrust has been given to the suggestion that individuals without any mental health problems may benefit from using psychedelic drugs, and that they may have a right to do so. This review considers contemporary research into the use of psychedelic drugs in healthy individuals, including neurobiological and subjective effects. In line with findings suggesting positive effects in the treatment of mental health problems, such research highlights the potential of psychedelic drugs for the enhancement of wellbeing even in healthy individuals. The relatively low risk associated with usage does not appear to align with stringent drug laws that impose heavy penalties for their use. Some policy implications, and suggestions for future research, are considered.